Cargando…

CircADARB1 serves as a new biomarker in natural killer T-cell lymphoma and a potential regulator of p-Stat3

BACKGROUND: Natural killer/T-cell lymphoma (NKTCL) is a rare and aggressive subtype of Non-Hodgkin’s Lymphoma. CircRNA has shown great potential to become a biomarker in plasma. In this study, we aimed to determine circRNA for its diagnostic and prognostic value and biological function in NKTCL. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mei, Mei, Wang, Yingjun, Song, Wenting, Li, Zhaoming, Wang, Qilong, Li, Jiayin, Zhang, Mingzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567645/ https://www.ncbi.nlm.nih.gov/pubmed/34736477 http://dx.doi.org/10.1186/s12935-021-02296-x

Ejemplares similares

CircCDYL Serves as a New Biomarker in Mantle Cell Lymphoma and Promotes Cell Proliferation
por: Mei, Mei, et al.
Publicado: (2019)

Case-control study of ADARB1 and ADARB2 gene variants in migraine
por: Gasparini, Claudia F, et al.
Publicado: (2015)

Conserved cell populations in doxorubicin-resistant human nasal natural killer/T cell lymphoma cell line: super multidrug resistant cells?
por: Zhang, Xudong, et al.
Publicado: (2018)

Causes of mortality in cases with extra nodal natural killer/T-cell lymphoma, nasal type: A cohort study
por: Mei, Mei, et al.
Publicado: (2019)

T-cell dysfunction in natural killer/T-cell lymphoma
por: Feng, Xiaoyan, et al.
Publicado: (2023)

Function of low ADARB1 expression in lung adenocarcinoma
por: Wang, Xiang, et al.
Publicado: (2019)

Non-coding RNAs in Natural Killer/T-Cell Lymphoma
por: Mei, Mei, et al.
Publicado: (2019)

Primary Causes of Death in Patients with Non-Hodgkin’s Lymphoma: A Retrospective Cohort Study
por: Mei, Mei, et al.
Publicado: (2020)

Role of downregulated ADARB1 in lung squamous cell carcinoma
por: Wang, Xiang, et al.
Publicado: (2020)

Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma
por: Li, Zhaoming, et al.
Publicado: (2019)

S100A9 and ORM1 serve as predictors of therapeutic response and prognostic factors in advanced extranodal NK/T cell lymphoma patients treated with pegaspargase/gemcitabine
por: Zhou, Zhiyuan, et al.
Publicado: (2016)

PARP inhibitor exerts an anti-tumor effect via LMO2 and synergizes with cisplatin in natural killer/T cell lymphoma
por: Wu, Jiazhuo, et al.
Publicado: (2023)

CircFBXL5 promotes the 5-FU resistance of breast cancer via modulating miR-216b/HMGA2 axis
por: Zhu, Mingzhi, et al.
Publicado: (2021)

Hsa_circ_0004831 serves as a blood-based prognostic biomarker for colorectal cancer and its potentially circRNA-miRNA-mRNA regulatory network construction
por: Xing, Linlin, et al.
Publicado: (2020)

Role of circular RNA in hematological malignancies
por: Mei, Mei, et al.
Publicado: (2019)

Aberrant Expression of ADARB1 Facilitates Temozolomide Chemoresistance and Immune Infiltration in Glioblastoma
por: Lu, Can, et al.
Publicado: (2022)

PB2388: ALTERATIONS OF THE GUT MICROBIOTA AS A NON-INVASIVE DIAGNOSTIC BIOMARKER FOR NATURAL KILLER/T-CELL LYMPHOMA
por: Shi, Zhuangzhuang, et al.
Publicado: (2023)

MicroRNA-155 is a potential molecular marker of natural killer/T-cell lymphoma
por: Zhang, Xudong, et al.
Publicado: (2016)

The Allelic Expression of RNA Editing Gene ADARB1 in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
por: Zeng, Jiajia, et al.
Publicado: (2023)

Circular RNA circ_IRAK3 contributes to tumor growth through upregulating KIF2A via adsorbing miR-603 in breast cancer
por: Wang, Fang, et al.
Publicado: (2022)

Gut microbiota as non-invasive diagnostic and prognostic biomarkers for natural killer/T-cell lymphoma
por: Shi, Zhuangzhuang, et al.
Publicado: (2023)

Anti-PD1 up-regulates PD-L1 expression and inhibits T-cell lymphoma progression: possible involvement of an IFN-γ-associated JAK-STAT pathway
por: Xue, Weili, et al.
Publicado: (2019)

Updating targets for natural killer/T-cell lymphoma immunotherapy
por: Xue, Weili, et al.
Publicado: (2021)

Glaucocalyxin A suppresses multiple myeloma progression in vitro and in vivo through inhibiting the activation of STAT3 signaling pathway
por: Li, Mei, et al.
Publicado: (2021)

Significant Diagnostic and Prognostic Value of FLAD1 and Related MicroRNAs in Breast Cancer after a Pan-Cancer Analysis
por: Mei, Mei, et al.
Publicado: (2021)

Role of programmed death ligands in effective T-cell interactions in extranodal natural killer/T-cell lymphoma
por: HAN, LIJUAN, et al.
Publicado: (2014)

Downregulated ADARB1 Facilitates Cell Proliferation, Invasion and has Effect on the Immune Regulation in Ovarian Cancer
por: Zhu, Wei, et al.
Publicado: (2021)

The DDGP (cisplatin, dexamethasone, gemcitabine, and pegaspargase) regimen for treatment of extranodal natural killer (NK)/T-cell lymphoma, nasal type
por: Zhang, Lei, et al.
Publicado: (2016)

YOD1 serves as a potential prognostic biomarker for pancreatic cancer
por: Zhang, Zhishuo, et al.
Publicado: (2022)

Circ_ZNF124 promotes non-small cell lung cancer progression by abolishing miR-337-3p mediated downregulation of JAK2/STAT3 signaling pathway
por: Li, Qianping, et al.
Publicado: (2019)

RNA sequencing reveals the expression profiles of circRNA and identifies a four-circRNA signature acts as a prognostic marker in esophageal squamous cell carcinoma
por: Wang, Weiwei, et al.
Publicado: (2021)

Identification of differentially expressed circRNAs and a novel hsa_circ_0000144 that promote tumor growth in gastric cancer
por: Wei, Jianming, et al.
Publicado: (2019)

Genetic polymorphisms of STAT3 correlated with prognosis in diffuse large B-cell lymphoma patients treated with rituximab
por: Hu, Yunfei, et al.
Publicado: (2014)

CircRFX3 contributes to glioma progression through the circRFX3-miR-1179/miR-1229-VASP axis
por: Li, Hongli, et al.
Publicado: (2021)

SCUBE3 serves as an independent poor prognostic factor in breast cancer
por: Huo, Qin, et al.
Publicado: (2021)

As a biomarker for gastric cancer, circPTPN22 regulates the progression of gastric cancer through the EMT pathway
por: Ma, Shuo, et al.
Publicado: (2021)

Utility of baseline, interim and end-of-treatment (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma patients treated with L-asparaginase/pegaspargase
por: Chang, Yu, et al.
Publicado: (2017)

Circular RNA hsa_circ_0003288 induces EMT and invasion by regulating hsa_circ_0003288/miR-145/PD-L1 axis in hepatocellular carcinoma
por: Xu, Guili, et al.
Publicado: (2021)

Construction of a circRNA-miRNA-mRNA network based on competitive endogenous RNA reveals the function of circRNAs in osteosarcoma
por: Qiu, Yu, et al.
Publicado: (2020)

circ-PTK2 (hsa_circ_0008305) regulates the pathogenic processes of ovarian cancer via miR-639 and FOXC1 regulatory cascade
por: Wu, San-Gang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_edfu409ouna9b9aht4nvrt2au2